08/27/2026
💡 The transition from clinical trials to full commercial supply in advanced therapies is a complex process that requires exceptional operational agility and strategic planning. At the heart of this journey is the importance of aligning manufacturing capacity with long-term goals and proactively managing risks.
Flexibility in manufacturing processes and robust facility design is essential. Incorporating redundancy in critical systems and leveraging digital technologies can help maintain product quality and consistency, especially during transitions.
Collaboration among development, manufacturing, and quality teams plays a pivotal role in minimizing bottlenecks, particularly during technology transfer. By identifying constraints early and ensuring supply chain readiness, we can pave the way for successful product commercialization.
Hear from our CFO as he shares insights that de-risk the path to commercial supply:
https://hubs.la/Q04v6NhP0
Aligning manufacturing capacity with long-term client goals ensures products transition smoothly with consistent performance at commercial volumes.